Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Immunol Immunother. 2011 Aug;60(8):1061-74. doi: 10.1007/s00262-011-1053-z. Epub 2011 Jun 9.

Cooperativity of adaptive and innate immunity: implications for cancer therapy.

Author information

1
Laboratory of Lymphocyte Function, Department of Biochemistry and Cancer Biology, School of Medicine, Meharry Medical College, Nashville, TN 37208, USA. ashanker@mmc.edu

Abstract

The dichotomy of immunology into innate and adaptive immunity has created conceptual barriers in appreciating the intrinsic two-way interaction between immune cells. An emerging body of evidence in various models of immune rejection, including cancer, indicates an indispensable regulation of innate effector functions by adaptive immune cells. This bidirectional cooperativity in innate and adaptive immune functions has broad implications for immune responses in general and for regulating the tumor-associated inflammation that overrides the protective antitumor immunity. Mechanistic understanding of this two-way immune cross-talk could provide insights into novel strategies for designing better immunotherapy approaches against cancer and other diseases that normally defy immune control.

PMID:
21656157
PMCID:
PMC3508514
DOI:
10.1007/s00262-011-1053-z
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Support Center